Abstract:Acute respiratory distress syndrome (ARDS) is a common destructive syndrome with high morbidity and mortality rates. Currently, few effective therapeutic interventions for ARDS are available. Clinical trials have shown that the effectiveness of aspirin is inconsistent. The contribution of platelets to the inflammatory response leading to the development of ARDS is increasingly recognized. The antiplatelet agent aspirin reportedly exerts a protective effect on acid- and hyperoxia-induced lung injury in murine models. Our previous study showed that pretreatment with aspirin exerts protective effects on hyperoxia-induced lung injury in mice. However, the mechanisms and therapeutic efficacy of aspirin in the posttreatment of hyperoxia-induced acute lung injury (ALI) remain unclear. In this study, we used a homozygous NF-κB-luciferase +/+ transgenic mouse model and treated mice with low-dose (25 μg/g) or high-dose (50 μg/g) aspirin at 0, 24, and 48 h after exposure to hyperoxia (inspired oxygen fraction (FiO 2 ) > 95%). Hyperoxia-induced lung injury significantly increased the activation of NF-κB in the lung and increased the levels of macrophages infiltrating the lung and reactive oxygen species (ROS), increased the HO-1, NF-κB, TNF-α, IL-1β, and IL-4 protein levels, and reduced the CC10, SPC, eNOS, Nrp-1, and IκBα protein levels in the lung tissue. Pulmonary edema and alveolar infiltration of neutrophils were also observed in the lung tissue of mice exposed to hyperoxia. However, in vivo imaging revealed that posttreatment with aspirin reduced luciferase expression, suggesting that aspirin might reduce NF-κB activation. Posttreatment with aspirin also reduced hyperoxia-induced increases in the numbers of lung macrophages, intracellular ROS levels, and the expression of TNF-α, IL-1β, and IL-4; it also increased CC10, SPC and Nrp-1 levels compared with hyperoxia exposure alone. Lung histopathology also indicated that the aspirin posttreatment significantly reduced neutrophil infiltration and lung edema compared with hyperoxia exposure alone. Aspirin effectively induces an anti-inflammatory response in a model of hyperoxia-induced lung injury. Thus, aspirin may have potential as a novel treatment for hyperoxia-induced ALI.

Aspirin Acetylates Nitric Oxide Synthase Type 3 in Platelets Thereby Increasing Its Activity.

Acetylsalicylic Acid Regulates Overexpressed Small GTPase RhoA in Vascular Smooth Muscle Cells Through Prevention of New Synthesis and Enhancement of Protein Degradation.

Regulation on RhoA in Vascular Smooth Muscle Cells under Inflammatory Stimulation Proposes a Novel Mechanism Mediating the Multiple-Beneficial Action of Acetylsalicylic Acid

Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action

Changes of Platelets Nitric Oxide Synthase Activity and Expression in Patients with Acute Coronary Syndromes

Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration

Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease

[Lysophosphatidic Acid Activates L-arginine/nitric Oxide Pathway of Platelets in Rats].

Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes

Mir-34B-3p May Promote Antiplatelet Efficiency of Aspirin by Inhibiting Thromboxane Synthase Expression

The Potential Pathway of L-arginine·L-aspartate for Inhibition of Platelet Function

Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

Aspirin can elicit the recurrence of gastric ulcer induced with acetic acid in rats.

Aspirin modulates production of pro-inflammatory and pro-resolving mediators in endothelial cells

Aspirin‐Mediated Acetylation of SIRT1 Maintains Intestinal Immune Homeostasis

Aspirin Attenuates Hyperoxia-Induced Acute Respiratory Distress Syndrome (ARDS) by Suppressing Pulmonary Inflammation via the NF-κB Signaling Pathway

Inhibition of peroxynitrite-mediated DNA strand cleavage and hydroxyl radical formation by aspirin at pharmacologically relevant concentrations: implications for cancer intervention.

Anticancer and Anti-Inflammatory Mechanisms of NOSH-Aspirin and Its Biological Effects

Polyaspartoyl·l-arginine Inhibits Platelet Aggregation Through Stimulation of NO Release from Endothelial Cells

Aspirin Protects Human Coronary Artery Endothelial Cells by Inducing Autophagy

Chronic Application of Low-Dose Aspirin Affects Multiple Parameters of Three Blood Cellular Types and Antithrombin Activity: A 1:1:1 Propensity Score Matching Analysis